Expression of vascular endothelial growth factor and receptor tyrosine kinases in cardiac ischemia/reperfusion injury

Cardiovascular Pathology

Volumn 16, Issue 5, 2007, Pages 291-299

  Infanger, Manfred ^a   Faramarzi, Shideh ^a   Grosse, Jirka ^a   Kurth, Ekkehard ^b   Ulbrich, Claudia ^a   Bauer, Johann ^c   Wehland, Markus ^a   Kreutz, Reinhold ^a   Kossmehl, Peter ^a   Paul, Martin ^a   Grimm, Daniela ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Bavarian Animal Health Service   (Germany)

^c MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

Author keywords

ACE inhibition; IGF 1; Ischemia; Myocardium; Receptor; Reperfusion; VEGF

Indexed keywords

ANGIOTENSIN I; COLLAGEN TYPE 4; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INSULIN; LAMININ; MESSENGER RNA; PROTEIN TYROSINE KINASE; PROTEOCHONDROITIN SULFATE; QUINAPRILAT; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; VASCULOTROPIN; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG POTENCY; ENZYME INHIBITION; FEMALE; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART VENTRICLE REMODELING; HYPOXIA; ISOLATED HEART; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; SWINE;

ANGIOTENSIN I; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; CHONDROITIN SULFATES; COLLAGEN TYPE IV; FEMALE; INSULIN-LIKE GROWTH FACTOR I; LAMININ; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, CARDIAC; PERFUSION; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, IGF TYPE 1; RNA, MESSENGER; SWINE; TETRAHYDROISOQUINOLINES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2; VENTRICULAR REMODELING;

EID: 34548473120     PISSN: 10548807     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carpath.2007.04.001     Document Type: Article

References (51)

1. Takeshita S., Tomiyama H., Yokoyama N., Kawamura Y., Furukawa T., Ishigai Y., Shibano T., Isshiki T., and Sato T. Angiotensin converting enzyme inhibition improves defective angiogenesis in the ischemic limb of spontaneously hypertensive rats. Cardiovasc Res 52 (2001) 314-320
2. Fabre J., Rivard A., Magner M., Silver M., and Isner J. Tissue inhibition of angiotensin converting enzyme activity stimulates angiogenesis in vitro. Circulation 99 (1999) 3043-3049
3. Unger T., Mattfeldt T., Lamberty V., Bock P., Mall G., Linz W., Scholkens B., and Gohlke P. Effect of early onset angiotensin converting enzyme inhibition on myocardial capillaries. Hypertension 20 (1992) 478-482
4. Banai S., Shweiki D., Pinson A., Chandra M., Lazarovici G., and Keshet E. Upregulation of vascular endothelial growth factor expression induced by myocardial ischemia: implications for coronary angiogenesis. Cardiovasc Res 28 (1994) 1176-1179
5. Sharma H., Wunsch M., Schmidt M., Schott R., Kandolf R., and Schaper W. Expression of angiogenic factors in collateralized swine myocardium. EXS 61 (1992) 255-260
6. Hashimoto E., Ogita T., Nakaoka T., Matsuoka R., Takao A., and Kira Y. Rapid induction of vascular endothelial growth factor expression by transient ischemia in the rat heart. Am J Physiol 267 (1994) H1948-H1954
7. Li J., Brown L., Hibberd M., Grossman J., Morgan J., and Simons M. VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis. Am J Physiol 270 (1996) H1803-H1811
8. Ferrara N., Houck K., Jakeman L., and Leung D. Molecular and properties of the vascular endothelial growth factor family of proteins. Endocrine Rev 13 (1992) 18-32
9. Infanger M., Shakibaei M., Kossmehl P., Hollenberg S., Grosse J., Faramarzi S., Schulze-Tanzil G., Paul M., and Grimm D. Intraluminal application of vascular endothelial growth factor enhances healing of microvascular anastomosis in a rat model. J Vasc Res 42 (2005) 202-213
10. Kossmehl P., Schonberger J., Shakibaei M., Faramarzi S., Kurth E., Habighorst B., von Bauer R., Wehland M., Kreutz R., Infanger M., Schulze-Tanzil G., Paul M., and Grimm D. Increase of fibronectin and osteopontin in porcine hearts following ischemia and reperfusion. J Mol Med 83 (2005) 626-637
11. Colognato H., and Yurchenco P. Form and function: the laminin family of heterotrimers. Dev Dyn 218 (2000) 213-234
12. Ekblom P., Forsberg E., Gullberg D., and Ekblom M. Laminin isoforms and epithelial development. In: Birchmeier W., and Birchmeier C. (Eds). Epithelial morphogenesis in development and disease (1999), Harwood Academic Publishers, Amsterdam (The Netherlands) 261-286
13. Miner J. Renal basement membrane components. Kidney Int 56 (1999) 2016-2024
14. Zuk A., and Matlin K. Induction of a laminin isoform and alpha(3)beta(1)-integrin in renal ischemic injury and repair in vivo. Am J Physiol Renal Physiol 283 (2002) F971-F984
15. Horio T., Maki T., Kishimoto I., Tokudome T., Okumura H., Yoshihara F., Suga S., Takeo S., Kawano Y., and Kangawa K. Production and autocrine/paracrine effects of endogenous insulin-like growth factor-1 in rat cardiac fibroblasts. Regul Pept 124 (2005) 65-72
16. Pricci F., Pugliese G., Romano G., Romeo G., Locuratolo N., Pugliese F., Mene P., Galli G., Casini A., Rotella C., and Di Mario U. Insulin-like growth factors I and II stimulate extracellular matrix production in human glomerular mesangial cells. Comparison with transforming growth factor-beta. Endocrinology 137 (1996) 879-885
17. Jiang Y., Cheng D., Levi E., and Singh L. IGF-1 increases laminin, cyclin D1, and P21Cip1 expression in glomerular mesangial cells: an investigation of the intracellular signaling pathway and cell-cycle progression. J Cell Biochem 98 (2006) 208-220
18. Nogueira A., Ast I., Patone G., Perschel F., Grimm D., and Paul M. Functional effects of acute coronary occlusion and catecholinergic stimuli on the isolated normothermic hemoperfused porcine heart. Clin Exp Hypertens 25 (2003) 235-255
19. Farquharson C., and Struthers A. Gradual reactivation over time of vascular tissue angiotensin I to angiotensin II conversion during chronic lisinopril therapy in chronic heart failure. JACC 39 (2002) 767-775
20. Mitrovic V., Mudra H., Bonzel T., Schmidt W., and Schlepper M. Hemodynamic and humeral effects of parental therapy with intravenously administered ACE inhibitor quinaprilat in patients with advanced heart failure. Z Kardiol 85 (1996) 823-838
21. Lazar H., Bao Y., Rivers S., Colton T., and Bernard S. High tissue affinity angiotensin-converting enzyme inhibitors improve endothelial function and reduce infarct size. Ann Thorac Surg 72 (2001) 548-554
22. Koyanagi S., Eastham C., Harrison D., and Marcus M. Transmural variation in the relationship between myocardial infarct size and risk area. Am J Physiol 242 (1982) H867-H874
23. Kossmehl P., Kurth E., Faramarzi S., Habighorst B., Shakibaei M., Wehland M., Kreutz R., Infanger M., Danser A., Grosse J., Paul M., and Grimm D. Mechanisms of apoptosis after ischemia and reperfusion: role of the renin-angiotensin system. Apoptosis 11 (2006) 347-358
24. Grimm D., Huber M., Jabusch H., Shakibaei M., Fredersdorf S., Paul M., Riegger G., and Kromer E. Extracellular matrix proteins in cardiac fibroblasts derived from rat hearts with chronic pressure-overload: effects of beta-receptor blockade. J Mol Cell Cardiol 33 (2001) 487-501
25. Rothermund L., Kreutz R., Kossmehl P., Fredersdorf S., Shakibaei M., Schulze-Tanzil G., Paul M., and Grimm D. Early onset of chondroitin sulfate and OPN expression in angiotensin II-dependent left ventricular hypertrophy. Am J Hypertens 15 (2002) 644-652
26. Shakibaei M., Zimmermann B., and Merker H. Changes in integrin expression during chondrogenesis in vitro: an immunomorphological study. J Histochem Cytochem 43 (1995) 1061-1069
27. Kossmehl P., Shakibaei M., Cogoli A., Infanger M., Curcio F., Schonberger J., Eilles C., Bauer J., Pickenhahn H., Schulze-Tanzil G., Paul M., and Grimm D. Weightlessness induced apoptosis in normal thyroid cells and papillary thyroid carcinoma cells via extrinsic and intrinsic pathways. Endocrinology 144 (2003) 4172-4179
28. Takagi H., King G., Robinson G., Ferrara N., and Aiello L. Adenosine mediates hypoxic induction of VEGF in retinal pericytes and endothelial cells. Invest Ophthalmol Vis Sci 37 (1996) 2165-2176
29. Ferrara N., and Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 18 (1997) 4-25
30. Shibuya M., Yamguchi S., Yamane A., Ikeda T., Tojo A., Matsushime H., and Sato M. Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (FLT) closely related to the fms family. Oncogene 5 (1990) 519-524
31. Terman B., Dougher V., Carrion M., Dimitrov D., Armellino D., Gospodarowicz D., and Bohlen P. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial growth factor. Biochem Biophys Res Commun 187 (1992) 1579-1586
32. Jakeman L., Winer J., Bennett G., Altar C., and Ferrara N. Binding sites for vascular endothelial growth factor are localized on endothelial cells in adult rat tissues. J Clin Invest 89 (1992) 244-253
33. Barleon B., Siemeister G., Martiny-Baron G., Weindel K., Herzog C., and Marme D. Vascular endothelial growth factor up-regulates its receptor fms-like tyrosine kinase 1 (FLT-1) and a soluble variant of FLT-1 in human vascular endothelial cells. Cancer Res 57 (1997) 5421-5425
34. Plate K., Breier G., Millauer B., Ullrich A., and Risau W. Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis. Cancer Res 53 (1993) 5822-5827
35. Siddiqui A., Mansson-Broberg A., Gustafsson T., Grinnemo K., Dellgren G., Hao X., Fischer H., and Sylven C. Antagonism of the renin-angiotensin system can counteract cardiac angiogenic vascular endothelial growth factor gene therapy and myocardial angiogenesis in the normal heart. Am J Hypertens 18 (2005) 1347-1352
36. Shimizu T., Okamoto H., Chiba S., Matsui Y., Sugawara T., Akino M., Nan J., Kumamoto H., Onozuka H., Mikami T., and Kitabatake A. VEGF-mediated angiogenesis is impaired in angiotensin type 1 receptor blockade in cardiomyopathic hamster hearts. Cardiovasc Res 58 (2003) 203-212
37. Cameliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 6 (2000) 389-395
38. Rice G., Thomas D., Grant P., Turner A., and Hooper N. Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism. Biochem J 383 (2004) 45-51
39. Williams H., Baker A., Gallacher B., and Lodwick D. Angiotensin II increases vascular permeability factor gene expression by human vascular smooth muscle cells. Hypertension 25 (1995) 913-917
40. Chintalgattu V., Nair D., and Katwa L. Cardiac myofibroblasts: a novel source of vascular endothelial growth factor (VEGF) and its receptors Flt-1 and KDR. J Mol Cell Cardiol 35 (2003) 277-286
41. Dean R., Edmondson S., Burrell L., and Bach L. Localization of the insulin-like growth factor system in a rat model of heart failure induced by myocardial infarction. J Histochem Cytochem 47 (1999) 649-660
42. Loennechen J., Stoylen A., Beisvag V., Wisloff U., and Ellingsen O. Regional expression of endothelin-1, ANP, IGF-1, and LV wall stress in the I/R rat heart. Am J Physiol 280 (2001) H2902-H2910
43. Yamada H., Fabris B., Allen A., Jackson B., Johnston C., and Mendelsohn F. Localization of angiotensin converting enzyme in rat heart. Circ Res 68 (1991) 1491-1499
44. Chen L., Prakash O., and Re R. The interaction of insulin and angiotensin II on the regulation of human neuroblastoma cell growth. Mol Chem Neuropathol 18 (1993) 189-196
45. Duerr R., Huang S., Miraliakbar H., Clark R., Chien K., and Ross Jr. J. Insulin-like growth factor-1 enhances ventricular hypertrophy and function during the onset of experimental cardiac failure. J Clin Invest 95 (1995) 619-627
46. Grimm D., Cameron D., Griese D., Riegger G., and Kromer E. Differential effects of growth hormone on cardiomyocyte and extracellular matrix protein remodeling following experimental myocardial infarction. Cardiovasc Res 40 (1998) 297-306
47. Schams D., Kosmann M., Berisha B., Amselgruber W., and Miyamoto A. Stimulatory and synergistic effects of luteinising hormone and insulin like growth factor 1 on the secretion of vascular endothelial growth factor and progesterone of cultured bovine granulosa cells. Exp Clin Endocrinol Diabetes 109 (2001) 155-162
48. Yurchenco P., and O'Rear J. Basal lamina assembly. Curr Opin Cell Biol 6 (1994) 674-678
49. Grimm D., Elsner D., Schunkert H., Pfeifer M., Griese D., Bruckschlegel G., Muders F., Riegger G., and Kromer E. Development of heart failure following isoproterenol administration in the rat: role of the renin-angiotensin system. Cardiovasc Res 37 (1998) 91-100
50. Grimm D., Kromer E., Bruckschlegel G., Böcker W., Holmer S., Riegger G., and Schunkert H. Regulation of extracellular matrix proteins in pressure-overload cardiac hypertrophy: contribution of the renin-angiotensin system. J Hypertens 16 (1998) 1345-1355
51. Kinoshita A., Urata H., Bumpus F., and Husain A. Measurement of angiotensin-I converting-enzyme inhibition in the heart. Circ Res 73 (1993) 51-60